Efficacy, effects and indications of semaglutide injection
Semaglutide injection (Wegovy) is a GLP-1 receptor agonist. Its main mechanism of action is to stimulate the secretion of insulin and inhibit the release of glucagon by simulating the action of glucagon-like peptide-1 (GLP-1), thereby helping to regulate blood sugar levels. In addition to its hypoglycemic effect, Wegovy also has a significant weight loss effect. The drug was originally developed to treat type 2 diabetes, but its weight-loss effects have also made it a treatment option for obese and overweight patients.
Wegovy reduces weight through multiple mechanisms. First, it reduces appetite by increasing feelings of fullness. As an incretin hormone, GLP-1 can stimulate insulin secretion after meals while inhibiting gastric emptying, prolonging the retention time of gastric contents, thereby producing a lasting feeling of satiety and reducing total food intake. Secondly, Wegovy can also improve sugar metabolism in the body, helping patients use the food they eat more efficiently. Combined with diet and exercise, Wegovy can help patients reduce calorie intake and promote weight loss.
In terms of indications,Wegovy is suitable for the following types of patients:
1. Obesity patients in adults andchildren aged 12 and above, that is, patients with a BMI (body mass index) greater than 30;
2. Adult patients who are overweight and accompanied by at least one weight-related disease, such as high blood pressure, high cholesterol, diabetes, etc. By losing weight,Wegovy can effectively reduce the risk of these diseases;
3. This drug is also suitable for obese or overweight adult patients with cardiovascular disease. It reduces the risk of major adverse cardiovascular events (such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) through weight loss and improved blood sugar control.
However,Wegovy is not suitable for use in combination with other GLP-1 receptor agonists or medicines containing semaglutide. Patients should choose the appropriate treatment plan based on their doctor's advice.
In terms of side effects,Common side effects of Wegovy include gastrointestinal discomfort symptoms such as nausea, vomiting, diarrhea and constipation. Most side effects are noticeable at the beginning of treatment, but patients get used to them over time.
Reference materials:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)